As of 2025-11-18, the Fair Value of Hemogenyx Pharmaceuticals PLC (HEMO.L) is -652.29 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 884.00 GBP, the upside of Hemogenyx Pharmaceuticals PLC is -173.79%.
With the market price of 884.00 GBP and our fair value calculation, Hemogenyx Pharmaceuticals PLC (HEMO.L) is not a good investment. Investing in HEMO.L stocks now will result in a potential loss of 173.79%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -2.08 | -5.10 | -3.98 | -6.69 | -5.62 | -4.69 |
| YoY growth | -43.54% | -144.89% | 21.96% | -68.14% | 16.01% | -43.72% |
| Market Cap (mil) | 52.92 |
| P/E | |
| Forward P/E |
| EPS | -130.46 |
| Avg earnings growth rate | -43.72% |
| TTM earnings | -7.81 |